{"id":"W1977465091","doi":"10.5489/cuaj.1891","title":"A multicentre analysis of abiraterone acetate in Canadian patients with metastatic castration resistant prostate cancer","year":2014,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; Juravinski Cancer Centre; Baker Hughes (Canada)","funders":"","keywords":"Abiraterone acetate; Medicine; Prostate cancer; Docetaxel; Internal medicine; Abiraterone; Oncology; Adverse effect; Cancer; Androgen deprivation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001109005,0.0006171339,0.001070332,0.001438031,0.002055365,0.001022318,0.001166305,0.0006034114,0.001760638],"category_scores_gemma":[0.002694502,0.0004845991,0.001216198,0.005040672,0.0007311065,0.0002658356,0.000845183,0.0007170633,0.000300238],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01491955,"about_ca_system_score_gemma":0.01647087,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8199719,"about_ca_topic_score_gemma":0.8621441,"domain_scores_codex":[0.9983603,0.0002086806,0.0001206772,0.0002674626,0.0006700362,0.0003727815],"domain_scores_gemma":[0.9973317,0.0002158454,0.0009072047,0.0001398537,0.0006808612,0.0007244644],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003302982,0.0002300047,0.9830912,0.0002731722,0.0005100043,0.0005757896,0.0005861927,0.0002366665,0.0009640832,0.00008193058,0.001583913,0.008564154],"study_design_scores_gemma":[0.000262294,0.0003837067,0.9972273,0.00002331148,0.0001381233,0.0003773965,0.0002134921,0.0001659467,0.00008818947,0.00001125702,0.001087765,0.00002126875],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955027,0.001072528,0.00005174775,0.0001413821,0.000008540394,0.000113978,0.002619881,0.000007016057,0.0004823149],"genre_scores_gemma":[0.9962091,0.000504736,0.0001742191,0.0001640553,0.00002095683,0.00004334138,0.002591646,0.000004932624,0.0002869891],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1800281,"threshold_uncertainty_score":0.3621766,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01288159536726978,"score_gpt":0.2624258442607687,"score_spread":0.2495442488934989,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}